Which techniques to use to assess disease response in multiple myeloma
Carlos Fernandez de Larrea
The epigenetics of multiple myeloma and the rationale for HDAC inhibitors
The multi-cohort SCHOLAR-1 study of refractory aggressive DLBCL
CTL019 in pediatric and young adult relapsed/refractory acute lymphoblastic leukemia (ALL) patients
How can MRD and disease be assessed in routine practice?